Skip to main content

Table 1 Clinicopathological characteristics of the patients

From: Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer

Variables

No. and (%)

HCC patients

No. of patients

188

Age (median; range), years

50; 13–76

Gender (male/female)

159/29 (84.6/15.4)

HBV infection (no/yes)

19/169 (10.1/89.9)

Alpha-fetoprotein, ng/mL (≤2 5/>25)

74/114 (39.4/60.6)

Child–Pugh class (A/B)

175/13 (93.1/6.9)

Tumor number (single/multiple)

144/44 (76.6/23.4)

Tumor size, cm (≤5/>5)

80/108 (42.6/57.4)

Vascular invasion (absent/present)

177/11 (94.1/5.9)

TNM stage (I/II/III)

130/16/39 (69.1/10.1/20.8)

Histological grade (I/II/III/other)

125/63 (66.5/33.5)

GC patients

No. of patients

138

Age (median; range), years

69; 28–78

Gender (male/female)

100/38 (72.5/27.5)

Tumor size, cm (≤4/>4)

46/92 (33.3/66.7)

Tumor depth (pT1/pT2/pT3/pT4)

3/10/34/91 (2.2/7.2/24.7/65.9)

Lymph node metastasis (pN0/pN1/pN2/pN3)

29/31/27/51 (21.0/22.5/19.5/37.0)

TNM stage (IA/IB/II/IIIA/IIIB/IIIC)

3/6/5/25/32/32/35 (2.2/4.3/3.6/18.1/23.2/23.2/25.4)

Histological grade (I/II/III/other)

3/32/90/11 (2.2/23.2/65.2/8.0)

  1. HCC hepatocellular carcinoma, GC gastric cancer, HBV hepatitis B virus, TNM tumor-lymph node-metastasis